Anti-infective Agents Market (Updated Version Available)

The Anti-infective Agents market had reached xxx million USD with a CAGR xx from 2015-2019. Later on, it will go to xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.
North America was one of the dominated countries in 2015 with a revenue generation of over USD 26.3 billion. The presence of sophisticated healthcare infrastructure and high awareness amongst the end-users such as clinicians and healthcare professionals in this region are estimated to be the key factors contributing to this large share. Moreover, in this region, the high purchasing power of expensive drugs and the presence of favorablereimbursement policies are the drivers projected to accentuate the growth of the anti-infective agents market.
Asia-Pacific is expected to witness significant growth over the forecast period owing to the presence of generics companies, the rising economic stability, and the increasing level of disposable income. In addition, the growing geriatric population base coupled with the increased susceptibility to infections is expected to provide a potential growth platform to this industry.
In the global Anti-infective Agents market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.

In global market, the following companies are covered:
Pfizer Inc.
Abbott Laboratories
Gilead Sciences, Inc.
Bristol-Myers Squibb Co.
Merck & Co., Inc.
Bayer Healthcare AG
AstraZeneca Plc.
Boehringer Ingelheim
Novartis AG
Astellas Pharma, Inc.
GlaxoSmithKline Plc.
Alcon Pharmaceuticals Ltd.
Sanofi-Aventis S.A.
Johnson & Johnson

Market Segment by Product Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs

Market Segment by Application
Hospital Use
Clinic Use
Household
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Anti-infective Agents market for the forecast period 2020 - 2025?
• What are the driving forces in the Anti-infective Agents market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Anti-infective Agents industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?